MCFD2 Inhibitors

MCFD2 inhibitors are a collection of chemicals primarily targeting the ER-Golgi transport mechanisms and related cellular processes. Many of these compounds, such as Brefeldin A and Monensin, focus on disrupting the Golgi apparatus and its function. Others, including Thapsigargin and Tunicamycin, induce ER stress, which can indirectly impact the function of transport proteins like MCFD2.

The compounds in this category range from those that directly act on the vesicle transport machinery to those that indirectly affect the cellular environment in which these transport processes occur. For example, Nocodazole's destabilization of microtubules can impede the physical infrastructure that supports vesicle transport. In contrast, agents like Forskolin elevate cAMP levels, disrupting vesicle trafficking through intracellular signaling.